• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD,INC. CADD CLEO INFUSION SETS; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD,INC. CADD CLEO INFUSION SETS; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number SET INFULIN 6MM/INSERTER/42 BUCKLE
Medical Device Problem Codes Loss of or Failure to Bond (1068); Infusion or Flow Problem (2964)
Health Effect - Clinical Code Hyperglycemia (1905)
Date of Event 10/03/2019
Type of Reportable Event Serious Injury
Event or Problem Description
Information received a smith medical cleo infusion set had several malfunctions where it caused consumer to have complications associated with diabetes.First noted the spring did not work.Secondly ,the glue between the plastic tape and solid part of device was not sticking; after one hour separated.The report states listed above malfunctions caused her to have hyperglycemia and close monitoring of blood glucose levels,checking for ketones in urine, which subsequentially caused interventions of insulin sliding scale injections with aide from hospital nurse.One other occasion th tube separated from the adhesive.The consumer provided pictures of the malfunctions.No other long term adverse events reported.Hyperglycemia can cause diabetic ketoacidosis.Interventions were required to preclude serious injury for risk of kidney failure, heart and most common cerebral edema.Critical care would need to be implemented to stabilize the patient.
 
Additional Manufacturer Narrative
Three photos of smiths medical cleo 90 infusion set, product number 21-7222-4, lot number 3793908 were received for review.On the first picture, it was observed that the tube was separated from the buckle, on the second picture it was observed that the buckle was partially connected to the cannula site and the third picture was a top view of the cap of the product.A review of manufacturing processes was performed.It was verified that procedures in the assembly process and quality check process were being properly followed.The investigation determined that a possible, but unconfirmed cause of the reported tubing separation issue was that adhesive was missing during visual inspection.The spring issue was not confirmed as no samples were returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD CLEO INFUSION SETS
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD,INC.
6000 nathan lane north
minneapolis MN 55442
MDR Report Key9325296
Report Number3012307300-2019-05981
Device Sequence Number18937210
Product Code FPA
UDI-Device Identifier30610586028353
UDI-Public30610586028353
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K042172
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer,distributor,user fac
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date05/30/2019
Device Model NumberSET INFULIN 6MM/INSERTER/42 BUCKLE
Device Catalogue Number21-7222-24
Device Lot Number3793908
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/15/2019
Supplement Date Received by Manufacturer01/28/2020
Initial Report FDA Received Date11/14/2019
Supplement Report FDA Received Date02/27/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-